搜索结果41-50 的 5917 / jhajjarcancer

  1. 神经科- 临床试验- 妙佑医疗国际

    :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

  2. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. ... Cancer” ( ...

  3. CAR-T 细胞疗法计划- 临床试验- 妙佑医疗国际

    The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

  4. 甲状腺癌- 症状与病因- 妙佑医疗国际

    Connect with others like you for support and answers to your questions in the Thyroid Cancer support group on Mayo Clinic Connect, a patient community. Thyroid ...

  5. 神经科- 临床试验- 妙佑医疗国际

    Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...

  6. 神经科- 临床试验- 妙佑医疗国际

    :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

  7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

  8. 神经科- 临床试验- 妙佑医疗国际

    :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

  9. 神经科- 临床试验- 妙佑医疗国际

    :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

  10. 神经科- 临床试验- 妙佑医疗国际

    :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...